Announcements
The FNIH Launches New Project to Reduce Treatment Times for Drug-Sensitive Tuberculosis
June 15, 2017 – The Foundation for the National Institutes of Health (FNIH) has launched a new project to shorten the treatment times of tuberculosis (TB) in drug-sensitive patients through individualized therapy. The $24 million project, “Using Biomarkers to Predict TB Treatment Duration” (PredictTB), is funded in-part by the FNIH through a $13 million donation from the Bill & Melinda Gates Foundation, with management support provided by the National Institute of Allergy and Infectious Diseases (NIAID) and Catalysis Foundation for Health.
Dr. Francis Collins to Continue Serving as NIH Director and FNIH Ex-Officio Board Member
June 7, 2017— The White House has announced that Francis Collins, M.D., Ph.D.—an ex-officio member of the Foundation for the National Institutes of Health (FNIH) Board of Directors—will continue to serve in the role of Director of the National Institutes of Health (NIH). The FNIH extends its congratulations to Dr. Collins on remaining in the role that he has maintained for the past eight years.
The FNIH Hires Robert L. Balthaser as Director of Advancement
February 1, 2017 – The Foundation for the National Institutes of Health (FNIH) has hired Robert L. Balthaser as the Director of Advancement. With 25 years of fundraising experience, Mr. Balthaser has held senior management positions, most recently at Independent Sector, Trust for the National Mall, American Foundation for Aids Research, New York University Child Study Center and Manhattan College. Mr.
The American Journal of Tropical Medicine and Hygiene Publishes Consensus Points from Global Experts on the Potential Risks of Using Gene Drive Mosquitoes to Control Malaria
December 9, 2016 – The American Journal of Tropical Medicine and Hygiene published a systematic evaluation of potential risks associated with the use of mosquitoes genetically modified through gene drive technology to reduce the burden of malaria in Africa.
Framework for Biomarker Evidentiary Criteria Released
December 6, 2016 — The Foundation for the National Institutes of Health (FNIH) announced today the release of the “Framework for Defining Evidentiary Criteria for Biomarker Qualification.” Developed in partnership with government and industry stakeholders, the framework defines the level of evidence needed to support qualification of biological markers (biomarkers). The document is a result of a broad-based effort by the FNIH, the U.S.
Foundation for the National Institutes of Health Receives Grant from Amie’s Place Foundation to Expand Research on the Benefits of Human-Animal Interaction
November 2, 2016 —The Foundation for the National Institutes of Health (FNIH) has received a $165,000 grant award from Amie’s Place Foundation, a New York-based not-for-profit dedicated to keeping families and pets together, to help advance research on the therapeutic benefits of human-
Training the Next Generation of Clinician Scientists through the NIH Medical Research Scholars Program (MRSP) Q&A with esteemed MRSP Alum Kyle Vining, DDS, Harvard University
October 25, 2016 — This fall, 52 medical and dental students began intensive research training at the National Institutes of Health (NIH) through the Medical Research Scholars Program (MRSP). This one-year program offers students opportunities to engage in research early in their careers, while addressing the critical need for a pipeline of talented scientists capable of turning discovery into improved health.
Salk Institute Presents FNIH Board Member Solomon H. Snyder, M.D., with Medal for Research Excellence
October 5, 2016 — Renowned neuroscientist Solomon H. Snyder, M.D., FNIH Board Vice Chairman for Science, was awarded the Salk Institute’s Medal for Research Excellence. This award, which has only been bestowed twice since the Salk Institute was established 56 years ago, honors individuals making significant contributions to basic science research with particular advances to policy, humanities, human health or the Institute.